Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?

BACKGROUND: Differential treatment between trial arms has been suggested to bias prostate cancer (PC) mortality in the European Randomized Study of Screening for Prostate Cancer (ERSPC). OBJECTIVE: To quantify the contribution of treatment differences to the observed PC mortality reduction between t...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Eur Urol
मुख्य लेखकों: Carlsson, Sigrid V., Månsson, Marianne, Moss, Sue, Kwiatkowski, Maciej, Recker, Franz, Tammela, Teuvo L.J., Bangma, Chris, Roobol, Monique J., Auvinen, Anssi, Hugosson, Jonas
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2019
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7526685/
https://ncbi.nlm.nih.gov/pubmed/30928162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.03.010
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन